232 related articles for article (PubMed ID: 32641979)
41. Dietary l-carnitine stimulates carnitine acyltransferases in the liver of aged rats.
Karlic H; Lohninger S; Koeck T; Lohninger A
J Histochem Cytochem; 2002 Feb; 50(2):205-12. PubMed ID: 11799139
[TBL] [Abstract][Full Text] [Related]
42. Myocardial carnitine palmitoyltransferase I expression and long-chain fatty acid oxidation in fetal and newborn lambs.
Bartelds B; Takens J; Smid GB; Zammit VA; Prip-Buus C; Kuipers JR; van der Leij FR
Am J Physiol Heart Circ Physiol; 2004 Jun; 286(6):H2243-8. PubMed ID: 14751860
[TBL] [Abstract][Full Text] [Related]
43. Carnitine palmitoyltransferase 2 deficiency: the time-course of blood and urinary acylcarnitine levels during initial L-carnitine supplementation.
Hori T; Fukao T; Kobayashi H; Teramoto T; Takayanagi M; Hasegawa Y; Yasuno T; Yamaguchi S; Kondo N
Tohoku J Exp Med; 2010 Jul; 221(3):191-5. PubMed ID: 20543534
[TBL] [Abstract][Full Text] [Related]
44. Carnitine palmitoyltransferase I activity monitoring in fibroblasts and leukocytes using electrospray ionization mass spectrometry.
Nolte L; van der Westhuizen FH; Pretorius PJ; Erasmus E
Anal Biochem; 1998 Feb; 256(2):178-84. PubMed ID: 9473275
[TBL] [Abstract][Full Text] [Related]
45. Establishing a relationship between prolactin and altered fatty acid β-oxidation via carnitine palmitoyl transferase 1 in breast cancer cells.
Linher-Melville K; Zantinge S; Sanli T; Gerstein H; Tsakiridis T; Singh G
BMC Cancer; 2011 Feb; 11():56. PubMed ID: 21294903
[TBL] [Abstract][Full Text] [Related]
46. CR reprograms acetyl-CoA metabolism and induces long-chain acyl-CoA dehydrogenase and CrAT expression.
Mezhnina V; Pearce R; Poe A; Velingkaar N; Astafev A; Ebeigbe OP; Makwana K; Sandlers Y; Kondratov RV
Aging Cell; 2020 Nov; 19(11):e13266. PubMed ID: 33105059
[TBL] [Abstract][Full Text] [Related]
47. Muscle Carnitine Palmitoyltransferase II (CPT II) Deficiency: A Conceptual Approach.
Joshi PR; Zierz S
Molecules; 2020 Apr; 25(8):. PubMed ID: 32295037
[TBL] [Abstract][Full Text] [Related]
48. Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer.
Fan Y; Zhou X; Xia TS; Chen Z; Li J; Liu Q; Alolga RN; Chen Y; Lai MD; Li P; Zhu W; Qi LW
Oncotarget; 2016 Mar; 7(9):9925-38. PubMed ID: 26848530
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of Metabolic Defects in Fatty Acid Oxidation Using Peripheral Blood Mononuclear Cells Loaded with Deuterium-Labeled Fatty Acids.
Yuasa M; Hata I; Sugihara K; Isozaki Y; Ohshima Y; Hara K; Tajima G; Shigematsu Y
Dis Markers; 2019; 2019():2984747. PubMed ID: 30881520
[TBL] [Abstract][Full Text] [Related]
50. JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance.
Wang T; Fahrmann JF; Lee H; Li YJ; Tripathi SC; Yue C; Zhang C; Lifshitz V; Song J; Yuan Y; Somlo G; Jandial R; Ann D; Hanash S; Jove R; Yu H
Cell Metab; 2018 Jan; 27(1):136-150.e5. PubMed ID: 29249690
[TBL] [Abstract][Full Text] [Related]
51. Longitudinal Metabolomic Profiling of Amino Acids and Lipids across Healthy Pregnancy.
Lindsay KL; Hellmuth C; Uhl O; Buss C; Wadhwa PD; Koletzko B; Entringer S
PLoS One; 2015; 10(12):e0145794. PubMed ID: 26716698
[TBL] [Abstract][Full Text] [Related]
52. Carnitine--metabolism and functions.
Bremer J
Physiol Rev; 1983 Oct; 63(4):1420-80. PubMed ID: 6361812
[TBL] [Abstract][Full Text] [Related]
53. Hydroxycarboxylic acid receptors are essential for breast cancer cells to control their lipid/fatty acid metabolism.
Stäubert C; Broom OJ; Nordström A
Oncotarget; 2015 Aug; 6(23):19706-20. PubMed ID: 25839160
[TBL] [Abstract][Full Text] [Related]
54. Altered hepatic fatty acid metabolism in endotoxicosis: effect of L-carnitine on survival.
Takeyama N; Takagi D; Matsuo N; Kitazawa Y; Tanaka T
Am J Physiol; 1989 Jan; 256(1 Pt 1):E31-8. PubMed ID: 2521428
[TBL] [Abstract][Full Text] [Related]
55. Carnitine supplementation and depletion: tissue carnitines and enzymes in fatty acid oxidation.
Negrao CE; Ji LL; Schauer JE; Nagle FJ; Lardy HA
J Appl Physiol (1985); 1987 Jul; 63(1):315-21. PubMed ID: 3624133
[TBL] [Abstract][Full Text] [Related]
56. Palmitate oxidation in human muscle: comparison to CPT and carnitine.
Shumate JB; Carroll JE; Brooke MH; Choksi RM
Muscle Nerve; 1982 Mar; 5(3):226-31. PubMed ID: 7088021
[TBL] [Abstract][Full Text] [Related]
57. Changes in kinetics of carnitine palmitoyltransferase in liver and skeletal muscle of dogs (Canis familiaris) throughout growth and development.
Lin X; Odle J
J Nutr; 2003 Apr; 133(4):1113-9. PubMed ID: 12672928
[TBL] [Abstract][Full Text] [Related]
58. Novel personalized pathway-based metabolomics models reveal key metabolic pathways for breast cancer diagnosis.
Huang S; Chong N; Lewis NE; Jia W; Xie G; Garmire LX
Genome Med; 2016 Mar; 8(1):34. PubMed ID: 27036109
[TBL] [Abstract][Full Text] [Related]
59. Metabolic Pathway Signatures Associated with Urinary Metabolite Biomarkers Differentiate Bladder Cancer Patients from Healthy Controls.
Kim WT; Yun SJ; Yan C; Jeong P; Kim YH; Lee IS; Kang HW; Park S; Moon SK; Choi YH; Choi YD; Kim IY; Kim J; Kim WJ
Yonsei Med J; 2016 Jul; 57(4):865-71. PubMed ID: 27189278
[TBL] [Abstract][Full Text] [Related]
60. Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosis.
Janzen N; Hofmann AD; Schmidt G; Das AM; Illsinger S
Orphanet J Rare Dis; 2017 Dec; 12(1):187. PubMed ID: 29268767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
